Prick-Test Nux avellana
Prick-Test Nux avellana is a medicine authorised by Swissmedic under authorisation number 61729. The authorisation holder is Dermapharm AG. The medicinal product code is Allergen: diagnostic and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 October 2010 and the authorisation is valid without a time limit. ATC code V04CL places the medicine in the group Diagnostic agents.
| Authorisation number | 61729 |
|---|---|
| Name | Prick-Test Nux avellana |
| Full name | Prick-Test Nux avellana, Pricktestlösung |
| Authorisation holder | Dermapharm AG |
| Medicinal product code | Allergen: diagnostic |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | V04CL |
| First authorisation | 18 October 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Prick-Test Nux avellana, Pricktestlösung | A | 18 October 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 3 ml | Flasche(n) | V04CL | 14.03.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Prick-Test Nux avellana authorised in Switzerland?
Yes. Prick-Test Nux avellana is authorised by Swissmedic under authorisation number 61729, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Prick-Test Nux avellana have?
Prick-Test Nux avellana is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Prick-Test Nux avellana?
The authorisation holder is Dermapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.